21-10-2008: Ontaril® closer to the market
Cellerix ends the recruitment for the first Phase III trial
It is sticking to the planned schedule, which is expected to be commercialized by 2011
13-10-2008: Joël Jean-Mairet to become Chairman of Cellerix
Eduardo González appointed Director.
1-10-2008: Cellerix obtains a 10M€ debt facility with ETV Capital
The biopharmaceutical company will be able to finalize clinical development of Ontaril®, its treatment for Perianal Fistulas for Crohn and non-Crohn patients.
20-05-2008: Guillermo Sellers named VP Medical and Regulatory of Cellerix
Cellerix has appointed Guillermo Sellers as the new Medical and Regulatory Vice President of its management team
22-04-2008: Miguel Fenoy, the New Director of Clinical Operations at Cellerix
Cellerix has appointed Miguel Fenoy to its team as Director of Clinical Operations.